相关实验视频

Updated: Jun 24, 2025

Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria

Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria

Published on: November 10, 2015

在乌干达人口中绘制药物遗传景观:在代表性不足的人口中对个性化医学的影响

Sumudu Rangika Samarasinghe¹, Seung-Been Lee², Manuel Corpas³

¹Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, Queensland, Australia.

Clinical pharmacology and therapeutics

|June 5, 2024

概括

这项研究揭示了乌干达人独特的药物遗传学特征,突出了影响药物代谢和反应的遗传变异. 这些发现对于个性化医疗和优化非洲人口中药物治疗至关重要.

科学领域:

基因组学就是基因组学.
药物基因组学药物基因组学
人口遗传学人口遗传学

背景情况:

非洲人在基因组研究中代表性不足,尽管疾病负担高,药用多种.
特定人口的遗传数据对于了解药物反应和减少不同非洲人口的不良事件至关重要.

研究的目的:

描述乌干达农村人口的药物基因组概况.
识别可操作的药物基因组变异,并将等位基因频率与其他全球人口进行比较.

主要方法:

对1998年乌干达个体的低通全基因组测序数据的分析.
使用PyPGx识别星基基因并与药物基因组学知识库 (PharmGKB) 进行比较.
基于既定剂量准则,对已识别的等位基因进行临床解释.

主要成果:

超过99%的参与者具有可操作的药物基因组表型,平均每人有3.5个可操作的基因型.
与其他非洲人群相比,乌干达队列中的特定变异性基因 (例如,CYP3A5*1,CYP2B6*9,CYP2D6*17) 的丰富.
显著比例预测药物反应受损 (CFTR,IFNL3,CYP2B6,CYP2C19) 和新陈代谢改变 (CYP2D6,CYP2C9,SLCO1B1,TPMT,DPYD).

结论:

乌干达人群拥有独特的药物基因组特征,可以影响药物的疗效和安全性.
这些发现强调了药物基因组学对于优化乌干达流行疾病治疗的重要性.
药物基因组学引导的疗法有可能促进精准医学的发展,并改善乌干达的医疗保健结果.

更多相关视频

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

相关概念视频

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...